132 related articles for article (PubMed ID: 1323139)
41. [Clinical evaluation of serum carbohydrate antigen 19-9 in carcinoma of the lung--a comparison with carcinoembryonic antigen].
Hayashibe A; Kodama T; Nishiwaki Y; Kudou H; Inoue Y; Nukariya N; Kaguraoka H; Kuroki M; Takahashi K; Nishiyama Y
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):711-5. PubMed ID: 3030198
[TBL] [Abstract][Full Text] [Related]
42. Serum concentrations of immunoglobulins and complement components in patients with recurrence after resection of gastric carcinoma.
Janssen CW; Tønder O; Matre R
Cancer Detect Prev; 1987; 10(3-4):303-9. PubMed ID: 3568028
[TBL] [Abstract][Full Text] [Related]
43. Beneficial effects of interleukin-2 on natural killer activity in lung cancer patients.
Ito M; Suzuki H; Yamashita N; Sugiyama E; Maruyama M; Sato M; Iwata M; Yano S
Anticancer Res; 1984; 4(6):375-8. PubMed ID: 6097158
[TBL] [Abstract][Full Text] [Related]
44. Antigenic heterogeneity of human lung cancers.
Harłozińska A; Richter R; Albert Z; Zawadzka H
J Natl Cancer Inst; 1983 Mar; 70(3):427-33. PubMed ID: 6300497
[TBL] [Abstract][Full Text] [Related]
45. [Immunological status in small cell and squamous cell lung cancer].
Janicka G; Przylipiak M; Chyczewska E; Kowal E
Pol Tyg Lek; 1983 Aug; 38(32):985-8. PubMed ID: 6320142
[No Abstract] [Full Text] [Related]
46. [Ca 19-9 and Ca 50 in the diagnosis of bronchial carcinoma: comparison with CEA].
Pecchio F; Rapellino M; Oliaro A; Moscato D; Adamo R; Albertino B; Lo Faso C; Faga C; Borasio P
Minerva Med; 1988 Mar; 79(3):183-6. PubMed ID: 2834670
[TBL] [Abstract][Full Text] [Related]
47. Diminished lymphocyte responses to phytohemagglutinin in lung cancer.
Hadjipetrou-Kourounakis L; Tsougranis A
Biochem Exp Biol; 1980; 16(4):357-64. PubMed ID: 6285942
[TBL] [Abstract][Full Text] [Related]
48. Studies on angiogenesis intensity in lung cancer in aspect of its correlation with histological type of tumor and clinical stage.
Juczewska M; Chyczewski L; Telego M; Chyczewska E; Nikliński J; Tańska M; Laudański J
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():254-70. PubMed ID: 9337543
[TBL] [Abstract][Full Text] [Related]
49. [Clinical studies of idiopathic interstitial pneumonia associated with lung cancer].
Kohno N; Takami S; Kamitsuna A; Ohnari K; Yamakido M; Nishimoto Y; Tsukiyama F
Nihon Naika Gakkai Zasshi; 1983 Dec; 72(12):1731-9. PubMed ID: 6327859
[No Abstract] [Full Text] [Related]
50. Serum immune complexes in erythema nodosum leprosum reactions of leprosy.
Rao TD; Rao PR
Indian J Lepr; 1988 Apr; 60(2):189-95. PubMed ID: 3142953
[TBL] [Abstract][Full Text] [Related]
51. [T-lymphocyte subsets and serum carcinoembryonic antigen in patients with lung cancer and its dynamic changes after therapy].
Zhang SC
Zhonghua Jie He He Hu Xi Za Zhi; 1991 Dec; 14(6):336-9, 376. PubMed ID: 1667986
[TBL] [Abstract][Full Text] [Related]
52. [Anti-tissue autoantibodies in malignant pulmonary neoplasms].
Ruffatti A; Visentin G; Giordano C; Bozzo R; De Silvestro G; Todesco S
Minerva Med; 1983 May; 74(22-23):1319-24. PubMed ID: 6304572
[TBL] [Abstract][Full Text] [Related]
53. Expression of CEA and trophoblastic cell markers by lung carcinoma in association with histological characteristics and serum marker levels.
Slodkowska J; Szturmowicz M; Rudzinski P; Giedronowicz D; Sakowicz A; Androsiuk W; Zakrzewska-Rowinska E
Eur J Cancer Prev; 1998 Feb; 7(1):51-60. PubMed ID: 9511851
[TBL] [Abstract][Full Text] [Related]
54. [Immunomorphology of lymph nodes and prognosis in lung cancer].
Di Giorgio A; Sammartino P; Canavese A; Arnone P; Sibio S; Accarpio F; Al Mansour M
Minerva Chir; 2001 Apr; 56(2):153-9. PubMed ID: 11353348
[TBL] [Abstract][Full Text] [Related]
55. Comparative evaluation of lymphocyte subpopulations, delayed cutaneous hypersensitivity reactions and autoantibody formation in cancer patients.
Pichler WJ; Stingl G; Wagner G; Micksche M; Neumann H; Knapp W
Osterr Z Onkol; 1977 Nov; 4(5-6):110-7. PubMed ID: 202907
[No Abstract] [Full Text] [Related]
56. Anti-elastin antibodies in patients with lung cancer.
Gmiński J; Mykała-Cieśla J; Machalski M; Drózdz M
Immunol Lett; 1992 Jul; 33(2):211-5. PubMed ID: 1332926
[TBL] [Abstract][Full Text] [Related]
57. Immunoglobulin content in the bronchial washings of patients with benign and malignant pulmonary disease.
Mandel MA; Dvorak KJ; Worman LW; DeCosse JJ
N Engl J Med; 1976 Sep; 295(13):694-8. PubMed ID: 958243
[TBL] [Abstract][Full Text] [Related]
58. Effects of sleep and sleep deprivation on immunoglobulins and complement in humans.
Hui L; Hua F; Diandong H; Hong Y
Brain Behav Immun; 2007 Mar; 21(3):308-10. PubMed ID: 17070668
[TBL] [Abstract][Full Text] [Related]
59. Immunologic studies of glycoproteins isolated from cell membranes of human lung carcinomas.
Tillack TW; Rosai J; Vervynck DJ
J Natl Cancer Inst; 1974 Apr; 52(4):1059-67. PubMed ID: 4133198
[No Abstract] [Full Text] [Related]
60. A comparison of lung cancer antigens.
Hollinshead AC; Sega E; Stewart TH; Ricci C; Mineo TC
Tumori; 1975; 61(2):125-8. PubMed ID: 179173
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
